Assessment of tumor response, alpha-fetoprotein (AFP) response, and time to progression (TTP) in the phase III CELESTIAL trial of cabozantinib (C) versus placebo (P) in advanced hepatocellular carcinoma (HCC) Meeting Abstract
| Authors: | Yau, T.; Merle, P.; Rimassa, L.; Ryoo, B. Y.; Cicin, I.; Harris, W. P.; Banu, E.; Sarker, D.; Tan, B.; van Vlierberghe, H.; Sen, S.; Love, C.; Cheng, A. L.; Meyer, T.; Kelley, R. K.; Abou-Alfa, G. K. |
| Abstract Title: | Assessment of tumor response, alpha-fetoprotein (AFP) response, and time to progression (TTP) in the phase III CELESTIAL trial of cabozantinib (C) versus placebo (P) in advanced hepatocellular carcinoma (HCC) |
| Meeting Title: | ESMO Asia Congress 2018 |
| Journal Title: | Annals of Oncology |
| Volume: | 29 |
| Issue: | Suppl. 9 |
| Meeting Dates: | 2018 Nov 23-25 |
| Meeting Location: | Singapore |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2018-11-01 |
| Start Page: | mdy432 |
| Language: | English |
| ACCESSION: | WOS:000458082200256 |
| PROVIDER: | wos |
| DOI: | 10.1093/annonc/mdy432 |
| Notes: | Meeting Abstract: 148O -- Source: Wos |
